SMTL ID : 6x4t.1 (1 other biounit)

Crystal structure of ICOS-L in complex with Prezalumab and VNAR domain

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.15 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: N.157, T.159, D.160 No protein-ligand interaction detected (PLIP)

5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 1 residues within 4Å: Chain A: N.86 No protein-ligand interaction detected (PLIP) NAG.3: 5 residues within 4Å: Chain A: Y.154, L.163, E.202, Q.207, N.209 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.207 NAG.4: 2 residues within 4Å: Chain A: N.170, R.188 No protein-ligand interaction detected (PLIP) NAG.5: 3 residues within 4Å: Chain A: M.12, N.121, Q.208 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.208 NAG.6: 3 residues within 4Å: Chain A: N.54, S.56 Chain C: S.30 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain C Hydrogen bonds: A:S.56, C:S.30

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.7: 3 residues within 4Å: Chain A: L.31, H.50, P.72 No protein-ligand interaction detected (PLIP) GOL.8: 3 residues within 4Å: Chain B: P.14, S.120, S.121 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:S.121

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rujas, E. et al., Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies. Nat Commun (2020)

Release Date

2020-10-14

Peptides

ICOS ligand: A
Prezalumab Fab Heavy chain: B
Prezalumab Fab Light chain: C
VNAR: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

C
F

D
G

ICOS ligand

Prezalumab Fab Heavy chain

Prezalumab Fab Light chain

VNAR

Related Entries With Identical Sequence